Sodium Benzoate
Pharmaceutical Premium
Pharmaceutical Excipient

Sodium Benzoate

High-purity pharmaceutical Sodium Benzoate manufactured to meet stringent USP and EP specifications for preservative applications. Our Sodium Benzoate provides excellent antimicrobial activity with broad-spectrum effectiveness for various pharmaceutical and oral formulations.

  • USP/EP Pharmaceutical Grade
  • Superior Preservative Properties
  • Excellent Antimicrobial Activity
  • Enhanced Stability
  • Consistent Quality
  • Ultra-Low Impurities

Technical Specifications

Chemical Formula: C7H5NaO2
CAS Number: 532-32-1
Molecular Weight: 144.10 g/mol
Physical State: White crystalline powder
Purity: ≥99.0% (USP/EP Grade)
pH (1% solution): 8.0-8.5
Loss on Drying: ≤2.0%
Chlorides: ≤0.01%
Sulfates: ≤0.015%
Heavy Metals (as Pb): ≤10 ppm
Readily Oxidizable: ≤1.0 mL KMnO4
Solubility: Freely soluble in water
Storage Conditions: Store at room temperature
Shelf Life: 5 years from date of manufacture
Packaging Options: 25kg, 50kg pharmaceutical containers

Applications

Pharmaceutical Preservative
Oral Liquid Formulations
Antimicrobial Agent
Injectable Preservative
Pharmaceutical Stabilizer
Capsule Formulations
Topical Preparations
Tablet Preservative
Cosmetic Preservative
Laboratory Reagent
Food Grade Preservative
USP/EP Applications

Industry-Specific Grades

DRAVYOM offers specialized Sodium Benzoate grades tailored for specific pharmaceutical and food preservation requirements, ensuring optimal antimicrobial performance and regulatory compliance across diverse application areas.

USP Grade (United States Pharmacopeia)
Purity: ≥99.0% Heavy Metals: ≤10 ppm Chlorides: ≤0.01% Application: FDA-compliant formulations
EP Grade (European Pharmacopoeia)
Purity: ≥99.0% pH: 8.0-8.5 (1% solution) Sulfates: ≤0.015% Application: EU regulatory submissions
Preservative Grade
Purity: ≥99.5% Antimicrobial Activity: Verified Microbiology: Compliant Application: Pharmaceutical preservatives
Food Grade
Purity: ≥99.0% E211 Specification: Met Microbiology: Compliant Application: Food preservation

Quality Standards

DRAVYOM's Sodium Benzoate is manufactured under stringent quality control protocols, meeting international pharmaceutical standards including USP, EP specifications. Our preservative-grade production ensures consistent performance and regulatory compliance.

ISO 9001:2015 Certified Manufacturing
USP/EP Grade Specifications
≥99.0% Purity
Advanced Antimicrobial Testing
Preservative Activity Verified
Microbiology Compliant
Comprehensive COA
Pharmaceutical Grade Packaging

Advanced Chemical Properties & Performance

Pharmaceutical Grade Sodium Benzoate exhibits exceptional chemical properties essential for preservation applications. Its potent antimicrobial structure and superior stability characteristics ensure reliable performance in demanding pharmaceutical preservation and buffering formulations.

Molecular Properties
Molecular Weight: 144.10 g/mol
Molecular Formula: C7H5NaO2
LogP (Octanol/Water): -1.6
pKa: 4.2 (benzoic acid)
Physical Properties
Melting Point: 410°C (decomposes)
Appearance: White granular or crystalline powder
Solubility (Water): Freely soluble (1 in 1.8)
Bulk Density: 0.60-0.70 g/cm³
Pharmaceutical Properties
Antimicrobial Activity: Broad-spectrum preservative
pH Range: Most effective at pH 2.5-4.0
Concentration: 0.1-0.2% for preservation
Stability: Stable under normal conditions
Quality Specifications
Purity: ≥99.0%
Water Content: ≤1.5%
Chloride: ≤300 ppm
Heavy Metals: ≤10 ppm
Stability Properties
Shelf Life: 5 years (unopened)
Storage Temperature: 15-25°C
Light Sensitivity: Stable to light
pH Stability: Stable in acidic conditions

Performance Characteristics

Detailed performance metrics demonstrate Sodium Benzoate superiority in preservation applications with exceptional antimicrobial efficacy, broad-spectrum activity, and stability across diverse pharmaceutical formulation and preservation systems.

Antimicrobial Activity

Broad-spectrum antimicrobial efficacy

Effective against bacteria, yeast, and molds
pH Dependent

Most effective in acidic pH range

Optimal activity at pH 2.5-4.0
High Solubility

Excellent water solubility

Easy incorporation in aqueous formulations
Heat Stability

Stable under processing temperatures

Maintains activity during manufacturing
Regulatory Status

FDA/GRAS approved preservative

Global regulatory acceptance
Cost Effective

Economical preservation solution

Low use levels required

Safety Information

Generally recognized as safe (GRAS) pharmaceutical preservative requiring standard handling protocols. Handle in controlled environments with appropriate dust control measures. Use proper personal protective equipment and follow established safety protocols for preservative materials.

GRAS Status
Standard PPE Required
Dust Control Measures

Storage & Handling

Store in tightly closed containers in a cool, dry place away from direct sunlight. Maintain controlled room temperature storage and ensure protection from moisture to preserve antimicrobial efficacy and pharmaceutical quality.

Controlled room temperature (15-25°C)
Store in dry conditions
Tightly closed containers
Preserve antimicrobial activity

Chemical Mechanisms & Reaction Pathways

Sodium Benzoate exhibits specific antimicrobial preservative mechanisms essential for pharmaceutical preservation. Its molecular structure enables effective microbial growth inhibition with predictable preservation therapeutic responses.

Antimicrobial Action

Benzoic acid release and microbial membrane disruption

Broad-spectrum preservation
pH-Dependent Activity

Optimal antimicrobial effectiveness at acidic pH ranges

Enhanced preservation efficiency
Microbial Selectivity

Effective against bacteria, yeasts, and molds

Comprehensive microbial control
Preservation Effects

Extended shelf life and product stability

Pharmaceutical quality assurance

Regulatory Compliance & Documentation

Comprehensive regulatory compliance ensures global pharmaceutical access with complete documentation packages supporting international drug development and manufacturing standards.

USP Specifications

United States Pharmacopeia pharmaceutical standards compliance

EP Standards

European Pharmacopoeia specifications for pharmaceutical quality

ICH Guidelines

International Conference on Harmonization standards compliance

GMP Certification

Good Manufacturing Practices certified production facility

DMF Support

Drug Master File documentation for regulatory submissions

CEP Available

Certificate of Suitability to European Pharmacopoeia monographs

Technical Support & Value-Added Services

DRAVYOM's pharmaceutical development team provides comprehensive formulation support, regulatory assistance, and technical services to optimize pharmaceutical performance in your specific drug development applications.

Formulation Development
  • Dosage form optimization support
  • Stability testing guidance
  • Bioavailability enhancement
  • Custom formulation development
Analytical Services
  • Method development and validation
  • Impurity profiling and identification
  • Stability indicating methods
  • Dissolution testing support
Regulatory Support
  • Regulatory submission assistance
  • DMF preparation and maintenance
  • Pharmacovigilance support
  • Global registration strategy
Supply Solutions
  • Pharmaceutical supply chain management
  • Cold chain logistics
  • Custom packaging solutions
  • Global distribution network

Environmental Impact & Sustainability

Our pharmaceutical production emphasizes environmental responsibility through sustainable manufacturing practices, green chemistry principles, and comprehensive environmental impact management for pharmaceutical operations.

Green Chemistry

Sustainable synthetic routes with minimal environmental impact

Water Management

Advanced wastewater treatment and recycling systems

Clean Production

Energy-efficient synthesis with emission controls

Safe Disposal

Comprehensive pharmaceutical waste management protocols

ISO 14001

Environmental management system certified production

Sustainable Packaging

Recyclable pharmaceutical packaging solutions

Manufacturing Excellence & Quality Control

DRAVYOM's state-of-the-art pharmaceutical manufacturing facility employs advanced synthesis technology and continuous monitoring systems to ensure consistent pharmaceutical quality and performance across all production batches.

Production Process

Advanced synthesis and purification in GMP-controlled clean-room environment

Multi-stage purification for pharmaceutical grade quality
Quality Testing

Comprehensive testing protocol including purity, potency, and impurity profiling

HPLC, GC-MS, and spectroscopic analysis
Quality Systems

ISO 9001:2015 and GMP quality management systems

Continuous improvement and validation protocols
Packaging Control

Pharmaceutical-grade packaging with controlled atmosphere

Contamination prevention and stability protection

Market Applications & Performance Data

Comprehensive pharmaceutical development data demonstrating effectiveness across diverse therapeutic applications with quantified performance metrics and clinical validation support.

Pharmaceutical Development
Formulation Success: 95+ formulations developed Regulatory Approvals: 100+ successful submissions Quality Consistency: 99.9% batch compliance
Research Applications
Clinical Studies: 200+ supported trials Publication Support: 150+ peer-reviewed papers Innovation: Custom API development
Commercial Manufacturing
Scale-up Success: 100% process transfers Supply Reliability: 99.8% on-time delivery Cost Optimization: 25% average cost reduction

DRAVYOM Competitive Advantages

Pharmaceutical Excellence

Consistently exceeds pharmacopeial specifications with superior purity and pharmaceutical performance

Reliable Supply

Guaranteed pharmaceutical availability with strategic inventory and GMP production scheduling

Development Expertise

Dedicated pharmaceutical development team provides formulation and regulatory support

Regulatory Assurance

Complete regulatory packages with DMF support and global registration assistance

Global Standards

International compliance with USP, EP, and ICH standards for worldwide market access

Partnership Approach

Collaborative relationships with pharmaceutical companies and custom development services